Anavex Life Sciences (AVXL) Operating Income Growth (1y) (2022 - 2025)
Anavex Life Sciences (AVXL) Operating Income Growth (1y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Anavex Life Sciences | 224.80 Mn | 93.05 Mn | - | 58.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 58.34% |
| Sep 30, 2025 | 24.01% |
| Jun 30, 2025 | 0.99% |
| Mar 31, 2025 | 0.88% |
| Dec 31, 2024 | -19.46% |
| Sep 30, 2024 | -12.73% |
| Jun 30, 2024 | -7.92% |
| Mar 31, 2024 | 11.04% |
| Dec 31, 2023 | 26.04% |
| Sep 30, 2023 | 17.18% |
| Jun 30, 2023 | -8.61% |
| Mar 31, 2023 | -23.18% |
| Dec 31, 2022 | -31.22% |